Will Roche Holding (RHHBY) Stock Be Helped By Seragon Pharmaceuticals Purchase?

NEW YORK (TheStreet) -- Roche Holding Ltd.  (RHHBY) will pay up to $1.725 billion to buy Seragon Pharmaceuticals, a privately-held, San Diego-based biotech company that researches breast cancer treatments, Reuters reports.

The company was spun out from Aragon Pharmaceuticals in 2013 when that company was bought by Johnson & Johnson  (JNJ), Reuters noted.

Roche Holding shares closed slightly lower at $37.29 yesterday.

Must Read: Warren Buffett's 25 Favorite Growth Stocks

 
RHHBY Chart

RHHBY data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Stocks Trade Lower as Amazon Rises, Apple and P&G Slump

Stocks Trade Lower as Amazon Rises, Apple and P&G Slump

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Video: The Road to S&P 500 2,800 Is 'Slow and Choppy'

Video: The Road to S&P 500 2,800 Is 'Slow and Choppy'

Let the Najarian Brothers Help You Generate Income With Options

Let the Najarian Brothers Help You Generate Income With Options

Oil Stocks Jump as Global Crude Oil Rally Gains Steam

Oil Stocks Jump as Global Crude Oil Rally Gains Steam